How to buy XRF Scientific shares | XRF historical share price and analysis

How to buy XRF Scientific shares

Own XRF Scientific shares in just a few minutes.

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

XRF Scientific Limited is a scientific & technical instruments business based in Australia. XRF Scientific shares (XRF) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. XRF Scientific has a trailing 12-month revenue of around $28.3 million.

How to buy shares in XRF Scientific

  1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for XRF Scientific . Find the share by name or ticker symbol: XRF. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until XRF Scientific reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of XRF Scientific . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

XRF Scientific share price

Use our graph to track the performance of XRF stocks over time.

XRF Scientific shares at a glance

Information last updated 2021-02-25.
52-week range$0.1245 - $0.34
50-day moving average $0.3033
200-day moving average $0.3029
Target price$0.22
PE ratio 10.3448
Dividend yield $0.014 (4.75%)
Earnings per share (TTM) $0.029

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Data updated regularly
Name Product Standard brokerage fee Inactivity fee Markets
Superhero share trading
AUD $5
No
ASX shares, ETFs
Pay zero brokerage on all Australian ETFs.
Trade ASX stocks with a flat $5 commission fee and a low minimum investment of just $100.
Bell Direct Share Trading
AUD $15
No
ASX shares, mFunds, ETFs
Exclusive: New customers who open an account with Bell Direct through Finder will pay no brokerage fees on the first five stock or ETF trades until April 30, 2021 (T&Cs apply).
Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.
IG Share Trading
Finder Award
IG Share Trading
AUD $8 or 0.1%
$50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
ThinkMarkets Share Trading
AUD $8
No
ASX shares, ETFs
Limited offer: Get 5 free ASX trades when you open a new account with ThinkMarkets before June 30, 2021 (T&Cs apply).
Buy and sell CHESS sponsored ASX shares with $0 brokerage on your first 5 trades. Only $8 flat fee brokerage thereafter, plus enjoy free live stock price data on an easy to use mobile app.
CMC Markets Stockbroking
AUD $11 or 0.1%
No
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.
ANZ Share Investing
AUD 19.95
No
ASX shares, Global shares, Options trading, mFunds, ETFs, Warrants
Earn 1 Qantas Point per AU$3 spent on brokerage fees on certain instruments.
Access Morningstar reports, company announcements and and live pricing via ANZ’s share investing platform. Available for desktop and mobile.
Westpac Online Investing Account
AUD 19.95 or 0.11%
USD 63.50 per year on the global markets account
ASX shares, Global shares, Options trading, ETFs
loading

Compare up to 4 providers

Is it a good time to buy XRF Scientific stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Is XRF Scientific under- or over-valued?

Valuing XRF Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of XRF Scientific 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

XRF Scientific 's P/E ratio

XRF Scientific 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, XRF Scientific shares trade at around 10x recent earnings.

That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

XRF Scientific 's EBITDA

XRF Scientific 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.1 million (£0.0 million).

The EBITDA is a measure of a XRF Scientific 's overall financial performance and is widely used to measure a its profitability.

XRF Scientific financials

Revenue TTM $28.3 million
Operating margin TTM 15.46%
Gross profit TTM $12.3 million
Return on assets TTM 6.23%
Return on equity TTM 11.04%
Profit margin 13.7%
Book value 0.269
Market capitalisation $40.4 million

TTM: trailing 12 months

XRF Scientific share dividends

Dividend payout ratio: 140% of net profits

Recently XRF Scientific has paid out, on average, around 140% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.75% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), XRF Scientific shareholders could enjoy a 4.75% return on their shares, in the form of dividend payments. In XRF Scientific 's case, that would currently equate to about A$0.014 per share.

XRF Scientific 's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

The latest dividend was paid out to all shareholders who bought their shares by 30 September 2020 (the "ex-dividend date").

Have XRF Scientific 's shares ever split?

XRF Scientific 's shares were split on 11 October 2007.

XRF Scientific share price volatility

Over the last 12 months, XRF Scientific 's shares have ranged in value from as little as $0.1245 up to $0.34. A popular way to gauge a stock's volatility is its "beta".

XRF.AU volatility(beta: 0.58)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while XRF Scientific 's is 0.5819. This would suggest that XRF Scientific 's shares are less volatile than average (for this exchange).

XRF Scientific overview

XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction material, and mining industries in Australia, Canada, and Europe. It operates through Capital Equipment, Precious Metals, and Consumables segments. The Capital Equipment segment designs, manufactures, and services automated fusion equipment, and high temperature test and production furnaces, as well as general laboratory equipment. The Precious Metals segment manufactures products for the laboratory and platinum alloy markets. The Consumables segment produces and distributes consumables, chemicals, and other supplies for analytical laboratories. The company is based in Osborne Park, Australia.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site